Working… Menu

BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01339442
Recruitment Status : Completed
First Posted : April 20, 2011
Last Update Posted : January 25, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Washington University School of Medicine

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 21, 2016
Actual Study Completion Date : December 28, 2016